IMV INC.

IMV
Delayed Quote. Delayed  - 12/03 04:00:00 pm
4.48CAD -1.10%

Turn to zoom
Prev.4.5300
Open4.4800
High4.7800
Low4.4200
Volume290 437
Latest news
6h ago
11/16
11/13
11/13
Chart IMV INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralBullish
Resistance5,267,946,87
Spread/Res.-13%-43%-34%
Spread/Supp.9,9%24%18%
Support4,143,683,87
Financials
Sales 2020 0,22 M 0,17 M 0,17 M
Net income 2020 -33,3 M -25,9 M -25,9 M
Net Debt 2020 - - -
P/E ratio 2020 -8,33x
Yield 2020 -
Capitalization 304 M 235 M 236 M
Capi. / Sales 2020 1 401x
Capi. / Sales 2021 258x
Nbr of Employees 62
Free-Float 99,4%
Company
IMV Inc. is a clinical stage biopharmaceutical company focused on developing cancer immunotherapies and vaccines against infectious diseases, including coronavirus disease 2019 (COVID-19). The Company develops cancer-targeted immunotherapies and vaccines based on the Company’s platform, DPX. The...

>> Read more
Sector :
Biotechnology & Medical Research - NEC
Calendar :
2020-12-03 Investor Meeting - Ovarian Cancer and Competitive Landscape
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 7,91 CAD
Last Close Price 4,53 CAD
Spread / Highest target 121%
Spread / Average Target 74,5%
Spread / Lowest Target -13,2%